Eli Lilly and Company

The momentum for this stock is not very good. Eli Lilly and Company is not very popular among insiders. Eli Lilly and Company is a mediocre stock to choose.
Log in to see more information.
Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical produc...

News

Vaughan David Investments LLC IL Sells 1,765 Shares of Eli Lilly and Company (NYSE:LLY)
Vaughan David Investments LLC IL Sells 1,765 Shares of Eli Lilly and Company (NYSE:LLY)

Ticker Report Vaughan David Investments LLC IL trimmed its position in Eli Lilly and Company (NYSE:LLY - Free Report) by 46.2% during the second quarter, according to the company in its most recent 13F filing with...\n more…

Eli Lilly Invests $1.8B To Expand Drug Output in Ireland
Eli Lilly Invests $1.8B To Expand Drug Output in Ireland

Investopedia Headlines Scott Olson / Getty Images\n\n Key TakeawaysEli Lilly is investing $1.8 billion to expand production in Ireland of its Alzheimer's treatment and weight-loss drugs.The company's Alzheimer's...\n more…

Looking At Eli Lilly's Recent Unusual Options Activity
Looking At Eli Lilly's Recent Unusual Options Activity

Benzinga Deep-pocketed investors have adopted a bullish approach towards Eli Lilly LLY, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LLY usually suggests something big is about to happen.\n more…

Roche Stock Down on Concerns of Side-Effects From Its Obesity Drug
Roche Stock Down on Concerns of Side-Effects From Its Obesity Drug

Zacks Investment Research Roche RHHBY presented results of an early-stage study on its experimental obesity drug, CT-996, at the European Association for the Study of Diabetes annual meeting.CT-996 is an investigational...\n more…

Quest Partners LLC Has $738,000 Stock Position in Eli Lilly and Company (NYSE:LLY)
Quest Partners LLC Has $738,000 Stock Position in Eli Lilly and Company (NYSE:LLY)

Ticker Report Quest Partners LLC lowered its stake in Eli Lilly and Company (NYSE:LLY - Free Report) by 16.0% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 815 shares of...\n more…

Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now
Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now

Yahoo! Finance: News Forget Eli Lilly and Novo Nordisk: This Could Be the Best Weight Loss Stock to Buy Right Now...\n more…